Skip to main content
Log in

Assessment of CFD Performance in Simulations of an Idealized Medical Device: Results of FDA’s First Computational Interlaboratory Study

  • Published:
Cardiovascular Engineering and Technology Aims and scope Submit manuscript

Abstract

While computational fluid dynamics (CFD) is commonly used for medical device development, its usefulness for demonstrating device safety has not been proven. Reliable standardized methods for this specialized need are lacking and are inhibiting the use of computational methods in the regulatory review of medical devices. To meet this need, participants from academia, industry, and the U.S. Food and Drug Administration recently completed a computational interlaboratory study to determine the suitability and methodology for simulating fluid flow in an idealized medical device. A technical working committee designed the study, defined the model geometry and flow conditions, and identified comparison metrics. The model geometry was a 0.012 m diameter cylindrical nozzle with a conical collector and sudden expansion on either side of a 0.04 m long, 0.004 m diameter throat, which is able to cause hemolysis under certain flow conditions. Open invitations to participate in the study were extended through professional societies and organizations. Twenty-eight groups from around the world submitted simulation results for five flow rates, spanning laminar, transitional, and turbulent flows. Concurrently, three laboratories generated experimental validation data on geometrically similar physical models using particle image velocimetry. The simulations showed considerable variation from each other and from experiment. One main source of error involved turbulence model underestimations of the centerline velocities in the inlet and throat regions, because the flow was laminar in these regions. Turbulence models were also unable to accurately predict velocities and shear stresses in the recirculation zones downstream of the sudden expansion. The wide variety in results suggest that CFD studies used to assess safety in medical device submissions to the FDA require careful experimental validation. Better transitional models are needed, as many medical devices operate in the transitional regime. It is imperative that the community undertake and publish quality validation cases of biofluid dynamics and blood damage that include complications such as pulsatility, secondary flows, and short and/or curved inlets and outlets. The results of this interlaboratory study will be available in a benchmark database to help develop improved modeling techniques, and consensus standards and guidelines for using CFD in the evaluation of medical devices.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15
Figure 16

Similar content being viewed by others

References

  1. Bludszuweit, C. Model for a general mechanical blood damage prediction. Artif. Organs 19:583–589, 1995.

    Article  Google Scholar 

  2. Burgreen, G. W., J. F. Antaki, Z. J. Wu, and A. J. Holmes. Computational fluid dynamics as a development tool for rotary blood pumps. Artif. Organs 25:336–340, 2001.

    Article  Google Scholar 

  3. de Wachter, D., and P. Verdonck. Numerical calculation of hemolysis levels in peripheral hemodialysis cannulas. Artif. Organs 26:576–582, 2002.

    Article  Google Scholar 

  4. Dumont, K., J. Vierendeels, R. Kaminsky, G. van Nooten, P. Verdonck, and D. Bluestein. Comparison of the hemodynamic and thrombogenic performance of two bileaflet mechanical heart valves using a CFD/FSI model. J. Biomech. Eng. 129:558–565, 2007.

    Article  Google Scholar 

  5. Dwyer, H. A., P. B. Matthews, A. Azadani, N. Jaussaud, L. Ge, T. S. Guy, and E. E. Tseng. Computational fluid dynamics simulation of transcatheter aortic valve degeneration. Interact. Cardiovasc. Thorac. Surg. 9:301–308, 2009.

    Article  Google Scholar 

  6. Fallon, A. M., L. P. Dasi, U. M. Marzec, S. R. Hanson, and A. P. Yoganathan. Procoagulant properties of flow fields in stenotic and expansive orifices. Ann. Biomed. Eng. 36:1–13, 2008.

    Article  Google Scholar 

  7. Fiore, G. B., U. Morbiducci, R. Ponzini, and A. Redaelli. Bubble tracking through computational fluid dynamics in arterial line filters for cardiopulmonary bypass. ASAIO J. 55:438–444, 2009.

    Article  Google Scholar 

  8. Gach, H. M., and I. J. Lowe. Measuring flow reattachment lengths downstream of a stenosis using MRI. J. Magn. Reson. Imaging 12:939–948, 2000.

    Article  Google Scholar 

  9. Garon, A., and M. I. Farinas. Fast three-dimensional numerical hemolysis approximation. Artif. Organs 28:1016–1025, 2004.

    Article  Google Scholar 

  10. Ge, L., H. L. Leo, F. Sotiropoulos, and A. P. Yoganathan. Flow in a mechanical bileaflet heart valve at laminar and near-peak systole flow rates: CFD simulations and experiments. J. Biomech. Eng. 127:782–797, 2005.

    Article  Google Scholar 

  11. Giersiepen, M., L. J. Wurzinger, R. Opitz, and H. Reul. Estimation of shear stress-related blood damage in heart valve prostheses—in vitro comparison of 25 aortic valves. Int. J. Artif. Organs 13:300–306, 1990.

    Google Scholar 

  12. Goubergrits, L., and K. Affeld. Numerical estimation of blood damage in artificial organs. Artif. Organs 28:499–507, 2004.

    Article  Google Scholar 

  13. Grigioni, M., U. Morbiducci, G. D’Avenio, G. D. Benedetto, and C. D. Gaudio. A novel formulation for blood trauma prediction by a modified power-law mathematical model. Biomech. Model. Mechanobiol. 4:249–260, 2005.

    Article  Google Scholar 

  14. Gross, J. M., M. C. Shu, F. F. Dai, J. Ellis, and A. P. Yoganathan. A microstructural flow analysis within a bileaflet mechanical heart valve hinge. J. Heart Valve Dis. 5:581–590, 1996.

    Google Scholar 

  15. Hariharan, P., M. Giarra, V. Reddy, S. Day, K. B. Manning, S. Deutsch, S. F. C. Stewart, M. R. Myers, M. R. Berman, G. W. Burgreen, E. G. Paterson, and R. A. Malinauskas. Experimental particle image velocimetry protocol and results database for validating computational fluid dynamic simulations of the FDA benchmark nozzle model. J. Biomech. Eng. 133:041002, 2011.

    Article  Google Scholar 

  16. He, Y., N. Duraiswamy, A. O. Frank, and J. E. Moore, Jr. Blood flow in stented arteries: a parametric comparison of strut design patterns in three dimensions. J. Biomech. Eng. 127:637–647, 2005.

    Article  Google Scholar 

  17. Hinds, M. T., Y. J. Park, S. A. Jones, D. P. Giddens, and B. R. Alevriadou. Local hemodynamics affect monocytic cell adhesion to a three-dimensional flow model coated with E-selectin. J. Biomech. 34:95–103, 2001.

    Article  Google Scholar 

  18. Izraelev, V., W. J. Weiss, B. Fritz, R. K. Newswanger, E. G. Paterson, A. Snyder, R. B. Medvitz, J. Cysyk, W. E. Pae, D. Hicks, B. Lukic, and G. Rosenberg. A passively suspended Tesla pump left ventricular assist device. ASAIO J. 55:556–561, 2009.

    Article  Google Scholar 

  19. Kameneva, M. V., G. W. Burgreen, K. Kono, B. Repko, J. F. Antaki, and M. Umezu. Effects of turbulent stresses upon mechanical hemolysis: experimental and computational analysis. ASAIO J. 50:418–423, 2004.

    Article  Google Scholar 

  20. Larsson, L., F. Stern, V. Bertram. Benchmarking of computational fluid dynamics for ship flows: the Gothenburg 2000 workshop. J. Ship. Res. 47:63–81, 2003.

    Google Scholar 

  21. Longest, P. W., and C. Kleinstreuer. Comparison of blood particle deposition models for non-parallel flow domains. J. Biomech. 36:421–430, 2003.

    Article  Google Scholar 

  22. Nobili, M., U. Morbiducci, R. Ponzini, C. Del Gaudio, A. Balducci, M. Grigioni, F. Maria Montevecchi, and A. Redaelli. Numerical simulation of the dynamics of a bileaflet prosthetic heart valve using a fluid–structure interaction approach. J. Biomech. 41:2539–2550, 2008.

    Article  Google Scholar 

  23. Oberkampf, W. L., and M. F. Barone. Measures of agreement between computation and experiment: validation metrics. J. Comput. Phys. 217:5–36, 2006.

    Article  MATH  Google Scholar 

  24. Oberkampf, W. L., T. G. Trucano, and C. Hirsch. Verification validation and predictive capability in computational engineering and physics. Appl. Mech. Rev. 57:345–384, 2004.

    Article  Google Scholar 

  25. Pant, S., N. W. Bressloff, A. I. Forrester, and N. Curzen. The influence of strut-connectors in stented vessels: a comparison of pulsatile flow through five coronary stents. Ann. Biomed. Eng. 38:1893–1907, 2010.

    Article  Google Scholar 

  26. Pinotti, M., and E. S. Rosa. Computational prediction of hemolysis in a centrifugal ventricular assist device. Artif. Organs 19:267–273, 1995.

    Article  Google Scholar 

  27. Raz, S., S. Einav, Y. Alemu, and D. Bluestein. DPIV prediction of flow induced platelet activation–comparison to numerical predictions. Ann. Biomed. Eng. 35:493–504, 2007.

    Article  Google Scholar 

  28. Sutera, S. P. Flow-induced trauma to blood cells. Circ. Res. 41:2–11, 1977.

    Google Scholar 

  29. Takano, T., S. Schulte-Eistrup, S. Kawahito, T. Maeda, K. Nonaka, J. Linneweber, J. Glueck, A. Fujisawa, K. Makinouchi, M. Yokokawa, and Y. Nosé. Inlet port positioning for a miniaturized centrifugal blood pump. Artif. Organs 26:45–48, 2002.

    Article  Google Scholar 

  30. Tamagawa, M., H. Kaneda, M. Hiramoto, and S. Nagahama. Simulation of thrombus formation in shear flows using lattice Boltzmann method. Artif. Organs 33:604–610, 2009.

    Article  Google Scholar 

  31. Williams, A. R. Shear-induced fragmentation of human erythrocytes. Biorheology 10:303–311, 1973.

    Google Scholar 

  32. Wu, J., J. F. Antaki, W. R. Wagner, T. A. Snyder, B. E. Paden, and H. S. Borovetz. Elimination of adverse leakage flow in a miniature pediatric centrifugal blood pump by computational fluid dynamics-based design optimization. ASAIO J. 51:636–643, 2005.

    Article  Google Scholar 

  33. Wu, J., B. E. Paden, H. S. Borovetz, and J. F. Antaki. Computational fluid dynamics analysis of blade tip clearances on hemodynamic performance and blood damage in a centrifugal ventricular assist device. Artif. Organs 34:402–411, 2010.

    Article  Google Scholar 

  34. Xenos, M., G. Girdhar, Y. Alemu, J. Jesty, M. Slepian, S. Einav, and D. Bluestein. Device Thrombogenicity Emulator (DTE)—design optimization methodology for cardiovascular devices: a study in two bileaflet MHV designs. J. Biomech. 43:2400–2409, 2010.

    Article  Google Scholar 

  35. Xu, Z., N. Chen, M. M. Kamocka, E. D. Rosen, and M. Alber. A multiscale model of thrombus development. J. R. Soc. Interface 5:705–722, 2008.

    Article  Google Scholar 

  36. Yano, T., K. Sekine, A. Mitoh, Y. Mitamura, E. Okamoto, D. W. Kim, I. Nishimura, S. Murabayashi, and R. Yozu. An estimation method of hemolysis within an axial flow blood pump by computational fluid dynamics analysis. Artif. Organs 27:920–925, 2003.

    Article  Google Scholar 

  37. Yeleswarapu, K. K., J. F. Antaki, M. V. Kameneva, and K. R. Rajagopal. A mathematical model for shear-induced hemolysis. Artif. Organs 19:576–582, 1995.

    Article  Google Scholar 

  38. http://aaac.larc.nasa.gov/tsab/cfdlarc/aiaa-dpw/.

  39. http://wind.nrel.gov/amestest/.

Download references

Acknowledgments

We recognize and appreciate the support of the worldwide CFD community. In particular, the authors wish to thank our study participants: Yared Alemu, K. Amano, J. Ashton, Mehdi Behbahani, Catrin Bludszuweit-Philipp, Danny Bluestein, Parnian Boloori-Zadeh, Alistair Brown, Scott Corbett, Julien de Charentenay, D. de Zelicourt, Wade Dummer, K. Fraser, Leonid Goubergrits, Kurt Graichen, Linden Heflin, Darren Hitt, Marcus Hormes, Marc Horner, Xueying Huang, S. Krishnan, S. Kühne, Patricia Lawford, Ming Li, Z. Li, William Louisos, Takehisa Mori, Alex Medvedev, Joerg Mueller, Sei Murakami, Mariagrazia Pilotelli, M. Polster, N. Reuel, T. Schauer, E. Sirois, Ken Solen, Ulrich Steinseifer, Wei Sun, S. Takahashi, Masaaki Tamagawa, K. Tan, Dalin Tang, Ertan Taskin, Z. Teng, R. Toyao, Dan White, Z. Jon Wu, M. Xenos, and Ajit Yoganathan. We also thank Dr. Jason Schroeder of the Office of Surveillance and Bioinformatics, CDRH, FDA, for performing statistical analyses. This study was supported by the Food and Drug Administration’s Critical Path Initiative. The mention of commercial products, their source, or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the U.S. Department of Health and Human Services.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sandy F. C. Stewart.

Additional information

Associate Editor Tim McGloughlin oversaw the review of this article.

Appendix: Best Practices

Appendix: Best Practices

CFD “Best Practices” identified in this study are listed below. These are not necessarily all-inclusive, nor do they guarantee an accurate simulation.

  1. (1)

    Identify the physics of the problem and choose the appropriate physical model.

  2. (2)

    Choose software carefully so that the physics of the problem can be properly captured.

  3. (3)

    If a turbulence model is used, justify the choice of the model and parameters used.

  4. (4)

    Correctly identify and quantify the necessary boundary conditions, initial conditions, material properties and other problem specifications.

  5. (5)

    Verify that the boundaries of the simulation do not interfere with the natural development and physical character of the flow.

  6. (6)

    Confirm that the simulation has numerically converged via residual reductions and/or monitoring of some physically relevant fluid flow quantity at a relevant probe point (or points) and/or surface location(s). For example, residuals of the algebraic solver for each dependent variable should be plotted. For steady simulations, three orders of magnitude drop is typically sufficient for an engineering analysis. Corresponding iterative convergence of both point and integral metrics should be plotted to determine the iterative error. For unsteady simulations, iterative convergence of algebraic solvers must be assessed, as well as the impact of outer correctors, and non-orthogonal correctors on the time-accuracy.

  7. (7)

    Perform a proper grid refinement study, preferably by doubling and quadrupling the grid density over the production grid. Choose reasonable variables of interest for convergence monitoring and a logical rationale for choosing the “best” mesh. In general, grid refinement studies are beneficial, but insufficient to ensure good results.

  8. (8)

    Validate the simulation with trustworthy experimental measurements of both local and global variables, using quantitative measures rather than side-by-side comparisons of contour plots. A global performance metric (e.g., pressure drop across a device) is rarely by itself a useful validation metric.

  9. (9)

    Validation should be performed against like or similar types of models.

  10. (10)

    Anisotropic boundary layer meshing used to resolve viscous effects should have mesh spacing that can be justified via physical reasoning.

  11. (11)

    Mesh cell type (e.g., triangular, tetrahedral, hexahedral) should be chosen with knowledge that different cell types have different numerical characteristics (e.g., artificial dissipation, limited order of spatial accuracies, etc.)

  12. (12)

    Portions of the flow domain meshed with a higher density than other regions should be chosen carefully with guidance from the intermediate solutions.

  13. (13)

    Make sure the results are reasonable and/or intuitive from a fluid mechanics point of view.

  14. (14)

    Ensure that basic conservation laws are obeyed. For example, in this study, the conservation of mass was checked by integrating velocity profiles. Other methods may need to be developed in other problems.

  15. (15)

    If available, use existing theoretical solutions (e.g., steady and unsteady pipe flow) and benchmark validation data (e.g., backward facing step) to check accuracy, simulation protocol, selection of parameters, etc. For example, the present sudden expansion case produces similar results to those found previously.8

  16. (16)

    When reporting results, provide plots with legends and labels. Contour plots may not be the best format for showing experimental validation or mesh convergence; quantitative results should be provided.

  17. (17)

    Some of the elementary errors made in this study suggest that training and experience are essential components to performing accurate simulations.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stewart, S.F.C., Paterson, E.G., Burgreen, G.W. et al. Assessment of CFD Performance in Simulations of an Idealized Medical Device: Results of FDA’s First Computational Interlaboratory Study. Cardiovasc Eng Tech 3, 139–160 (2012). https://doi.org/10.1007/s13239-012-0087-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13239-012-0087-5

Keywords

Navigation